ESA intolerant
Showing 26 - 50 of 628
Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)
Recruiting
- Non-small-cell Lung Carcinoma
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
May 11, 2023
Bladder Cancer Trial (Disitamab Vedotin for Injection,Penpulimab Injection)
Not yet recruiting
- Bladder Cancer
- Disitamab Vedotin for Injection,Penpulimab Injection
- (no location specified)
Aug 2, 2022
Autoimmune Inner Ear Disease Trial in New Hyde Park (Anakinra 100Mg/0.67Ml Inj Syringe (Period 1), Placebo injection (Period 1),
Recruiting
- Autoimmune Inner Ear Disease
- Anakinra 100Mg/0.67Ml Inj Syringe (Period 1)
- +3 more
-
New Hyde Park, New YorkNorthwell Health, Hearing& Speech Center
Oct 18, 2022
Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Newport Beach, California
- +2 more
Nov 10, 2023
Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)
Not yet recruiting
- Essential Thrombocythemia
- Bomedemstat
- +4 more
- (no location specified)
Oct 6, 2023
Unresectable Pancreatic Cancer Trial in Sendai-shi, Miyagi, Shinjuku-ku, Tokyo, Yokohama-shi, Kanagawa (Suizenji, Nal-IRI/FL,
Recruiting
- Unresectable Pancreatic Cancer
- Suizenji
- +3 more
-
Sendai-shi, Miyagi, Japan
- +2 more
Jan 31, 2023
Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC) Trial in France, Spain, United
Recruiting
- Unresectable Hepatocellular Carcinoma (HCC)
- Liver Metastases From Colorectal Cancer (mCRC)
- SIRT
-
Clichy, Cedex, France
- +8 more
Jul 31, 2023
Kidney Failure, Chronic Trial in Seoul (Monofer (experimental), control group)
Not yet recruiting
- Kidney Failure, Chronic
- Monofer (experimental)
- control group
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 5, 2023
Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))
Not yet recruiting
- Colorectal Neoplasms
- Resin microspheres containing yttrium-90 (Y-90)
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023
Lupus Erythematosus, Cutaneous, Subacute, Chronic Cutaneous Lupus Erythematosus Trial (BIIB059 (litifilimab))
Not yet recruiting
- Lupus Erythematosus, Cutaneous, Subacute
- Chronic Cutaneous Lupus Erythematosus
- BIIB059 (litifilimab)
- (no location specified)
Sep 12, 2023
Barrett's Esophagus With Dysplasia Trial in Sweden, United Kingdom, United States (EndoRotor Mucosal Resection System, Continued
Recruiting
- Barrett's Esophagus With Dysplasia
- EndoRotor Mucosal Resection System
- Continued Ablation
-
Rochester, Minnesota
- +4 more
Aug 1, 2022
Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)
Recruiting
- Chronic Myelogenous Leukemia - Chronic Phase
-
Birmingham, Alabama
- +25 more
Jan 10, 2023
Invasive Candidiasis, Mucocutaneous Candidiasis, Coccidioidomycosis Trial in Worldwide (Ibrexafungerp)
Active, not recruiting
- Invasive Candidiasis
- +9 more
-
Birmingham, Alabama
- +36 more
Jan 25, 2023
Hepatocellular Cancer Trial in Phoenix, Chicago, Winston-Salem (device, drug, other)
Recruiting
- Hepatocellular Cancer
- TheraBionic Device
- +2 more
-
Tampa, Florida
- +6 more
Dec 12, 2022
Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)
Not yet recruiting
- Lymphoma, Non-Hodgkin
-
Perth, Western Australia, AustraliaLinear Clinical Research Ltd
Apr 20, 2023
Hyperlipidemia Trial in Leuven (Cholesfytol NG®) supplement)
Completed
- Hyperlipidemia
- Cholesfytol NG®) supplement
-
Leuven, BelgiumCliniques universitaires St-Luc and Institut de Recherche Expéri
Aug 18, 2023
Anemia Associated With Chronic Kidney Disease (CKD) Trial in United States (Vadadustat, Mircera®)
Active, not recruiting
- Anemia Associated With Chronic Kidney Disease (CKD)
-
Huntsville, Alabama
- +57 more
Jan 31, 2022
Ulcerative Colitis Trial in Worldwide (Mirikizumab, Placebo)
Sleep Apnea, Obstructive, Apnea, Sleep Trial in United States (aerSleep II)
Recruiting
- Sleep Apnea, Obstructive
- Apnea, Sleep
- aerSleep II
-
Tucson, Arizona
- +14 more
Dec 7, 2022
r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase
Not yet recruiting
- B-cell Lymphoma
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Aug 9, 2022
Glioblastoma Multiforme Trial in Australia, United States (Nativis Voyager RFE Therapy)
Completed
- Glioblastoma Multiforme
- Nativis Voyager RFE Therapy
-
Birmingham, Alabama
- +12 more
Jan 31, 2023
Second-line Pharmacotherapy Patterns and Outcomes of Advanced
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Guangzhou, Guangdong, ChinaThe first affiliated hospital,Sun yat-sen university
Jun 30, 2022
Healthy Volunteers Trial in Lille (Group (A1 ? A2), Group (A2 ? A1))
Completed
- Healthy Volunteers
- Group (A1 → A2)
- Group (A2 → A1)
-
Lille, Nord, FranceNutrInvest - Institut Pasteur de Lille
Apr 5, 2022